CFGS
IBB icon

Concourse Financial Group Securities’s iShares Biotechnology ETF IBB Stock Holding History

Concourse Financial Group Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-710
Closed -$96.8K – 968
2024
Q4 		$96.8K Buy
710
+49
+7% +$6.89K 0.01% 958
2024
Q3 		$96.2K Buy
661
+5
+0.8% +$723 0.01% 948
2024
Q2 		$90K Buy
656
+120
+22% +$16K 0.01% 963
2024
Q1 		$73.5K Sell
536
-34
-6% -$4.64K ﹤0.01% 1030
2023
Q4 		$77.4K Sell
570
-13
-2% -$1.59K 0.01% 982
2023
Q3 		$71.4K Sell
583
-85
-13% -$10.8K 0.01% 956
2023
Q2 		$84.8K Sell
668
-123
-16% -$16K 0.01% 911
2023
Q1 		$102K Sell
791
-25
-3% -$3.27K 0.01% 863
2022
Q4 		$107K Sell
816
-20
-2% -$2.58K 0.01% 819
2022
Q3 		$98K Sell
836
-256
-23% -$31.8K 0.01% 727
2022
Q2 		$128K Sell
1,092
-168
-13% -$19.9K 0.01% 723
2022
Q1 		$164K Sell
1,260
-578
-31% -$75.3K 0.01% 702
2021
Q4 		$281K Buy
1,838
+113
+7% +$17.5K 0.02% 617
2021
Q3 		$279K Buy
1,725
+41
+2% +$6.9K 0.02% 608
2021
Q2 		$276K Sell
1,684
-787
-32% -$121K 0.02% 624
2021
Q1 		$372K Sell
2,471
-50,853
-95% -$8.08M 0.03% 483
2020
Q4 		$8.08M Sell
53,324
-27,731
-34% -$3.96M 0.61% 34
2020
Q3 		$11M Buy
81,055
+23,945
+42% +$3.25M 0.96% 21
2020
Q2 		$7.81M Buy
57,110
+53,004
+1,291% +$6.76M 0.76% 30
2020
Q1 		$442K Buy
4,106
+311
+8% +$35.8K 0.05% 273
2019
Q4 		$457K Buy
3,795
+1,974
+108% +$220K 0.05% 313
2019
Q3 		$182K Sell
1,821
-1,947
-52% -$204K 0.05% 311
2019
Q2 		$411K Buy
3,768
+133
+4% +$14.1K 0.04% 300
2019
Q1 		$406K Buy
3,635
+2,304
+173% +$253K 0.04% 306
2018
Q4 		$128K Sell
1,331
-5,583
-81% -$593K 0.02% 563
2018
Q3 		$843K Buy
+6,914
New +$814K 0.24% 91

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Concourse Financial Group Securities's IBB Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 710 shares — an estimated $96.8K sold.

Concourse Financial Group Securities first reported a position in IBB in Q3 2018 and held it in 26 quarters. The position peaked at $11M in Q3 2020. 832 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 710 iShares Biotechnology ETF shares in Q1 2025, an estimated $96.8K.
  • Concourse Financial Group Securities first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's iShares Biotechnology ETF position peaked at $11M in Q3 2020.
  • 832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.